Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration

Pharmacokinetics of Enoxaparin in Intensive Care Patients

NCT02095509 ·Status: COMPLETED ·Phase: PHASE4

Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.

NCT06705829 ·Status: RECRUITING

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4

Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage

NCT06974396 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects

NCT02171468 ·Status: COMPLETED ·Phase: PHASE1

Administration of Fibrinogen Concentrate for Refractory Bleeding

NCT05091684 ·Status: TERMINATED ·Phase: PHASE2

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

NCT05926518 ·Status: COMPLETED

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

NCT02295150 ·Status: UNKNOWN ·Phase: PHASE4

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

NCT05641142 ·Status: RECRUITING ·Phase: NA

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

NCT05548062 ·Status: ACTIVE_NOT_RECRUITING

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

NCT04234698 ·Status: COMPLETED

Pharmacogenetics of Warfarin in Puerto Ricans.

NCT01318057 ·Status: COMPLETED

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

NCT01004939 ·Status: COMPLETED

Study on Antithrombotic Prevention in Thrombophilia and Pregnancy Loss

NCT02385461 ·Status: UNKNOWN

A Prospective Pharmacodynamic Study of Rivaroxaban

NCT01743898 ·Status: COMPLETED

Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic Patients

NCT05301829 ·Status: UNKNOWN

Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

NCT00511173 ·Status: COMPLETED ·Phase: PHASE4

A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

NCT05178550 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Thromboprophylaxis for Patients in ICU With COVID-19

NCT04623177 ·Status: COMPLETED

Sources of the Variability of the Response to Fluindione in Elderly Patients (PREPA)

NCT00313469 ·Status: COMPLETED

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

NCT01727401 ·Status: TERMINATED ·Phase: PHASE4

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

NCT03296033 ·Status: TERMINATED ·Phase: PHASE4

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1